Navigation Links
Helix BioPharma Completes Definitive GLP Toxicology Studies With L-DOS47 and is Making Final Preparations for its Planned Phase I/II Clinical Study IND/CTA Submissions
Date:10/12/2010

AURORA, Ontario, Oct. 12 /PRNewswire/ -- Helix BioPharma Corp. (TSX, NYSE Amex, FSE: HBP) today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47.   These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix's positive findings from its preliminary non-GLP toxicology studies.  

The Company plans to conduct a Phase I study in the U.S. in patients with refractory solid tumors and a  Phase I/II, multi-arm safety and preliminary efficacy study in patients with stage III/IV non-small cell lung cancer in Poland.  It intends to use the findings from its GLP toxicology studies to complete the necessary protocol designs and other supportive documentation, as final steps in preparing its U.S. Phase I IND and its Polish Phase I/II CTA dossiers.  As a result of some delays in completing its GLP toxicology studies, Helix now expects these IND/CTA submissions to be made in its second rather than its first quarter of fiscal 2011.  

"We are very pleased to reach this important clinic-enabling milestone in our L-DOS47 development program," said John Docherty, Helix president and COO.  "Having completed these studies, Helix believes it now has a sufficient preclinical pharmacology and toxicology database to support human clinical testing with this important new drug candidate.  Helix is committed to completing these submissions as soon as possible, as it is no longer waiting for any further preclinical study findings before doing so."

About Helix BioPharma Corp.Helix BioPharma Corp. is a biopharmaceutical company focused on cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies.  Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new dr
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
2. Helix BioPharma Announces $11.4 Million Private Placement
3. Helix Biopharma Closes $11.4 Million Private Placement
4. Helix BioPharma Corp. Announces Fiscal 2008 Results
5. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
6. Helix BioPharma Announces Q1 2009 Financial Results
7. London-Based Double Helix Consulting Launches US Division for Strategic Pricing, Reimbursement and Market Access Solutions
8. Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
9. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
10. Helix BioPharma Announces Q2 2009 Financial Results
11. Double Helix Appoints Ann Stuchiner Vice President of US Consulting Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/25/2015)... Menomonie, Wis. (PRWEB) , ... August 25, 2015 ... ... and fermentor at its research facility in Knapp, Wis. The company has added ... Biostat C15 Fermentor allows detailed data collection during bacterial or fungal fermentation process ...
(Date:8/25/2015)... ... August 25, 2015 , ... ... blade-based and rackmount computing infrastructure, today announced the launch of its next ... The latest system boasts two distinct, individually sledded workstation nodes in each ...
(Date:8/25/2015)... ... ... Temarry Recycling first received approval from the DLA (Defense Logistics Agency) in ... the DLA’s ongoing efforts to ensure that all disposal facilities they do business with ... In fact, any disposal facility that receives waste from the Federal Government must be ...
(Date:8/25/2015)... ... 2015 , ... Knowledgent , the data and analytics firm, today announced ... ensuring top companies get the best insights out of their massive volumes of data. ... as you think about the purpose of Data Governance, it is one of the ...
Breaking Biology Technology:New centrifuge and fermentor expand product development capacity at Vets Plus 2Cirrascale® Announces Next Generation High Density, Two-in-One GPU Rackmount Offering Perfect for High Performance Remote Workstations 2Cirrascale® Announces Next Generation High Density, Two-in-One GPU Rackmount Offering Perfect for High Performance Remote Workstations 3Temarry Recycling Passes Defense Logistics Agency Audit With Flying Colors 2New White Paper Explores How Governance Enables Successful Data Initiatives 2
... Receives $249,500 in Additional Financing, YONKERS, N.Y., ... Board: ADVR), announced today that it has,commenced a ... healing., The Phase IIb trial is being ... Germany, led by Eckhart Kampgen, M.D.,Associate Professor for ...
... Pharma (N30), a,biopharmaceutical company focused on the discovery, ... bioavailability,announced today that it has completed a financing ... use proceeds from this financing to advance its ... and preclinical,research in the area of small molecule ...
... Fund Up to $25 Million to Advance P-552, ... Kainos,Medicines, Inc. today announced that they have entered into ... P-552,for the treatment of dry mouth associated with primary ... collaborate in the clinical,development of P-552. Kainos will provide ...
Cached Biology Technology:Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 2Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123 3N30 Pharma Announces Financing, Expansion of Board 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 2Parion Sciences and Kainos Medicines Sign Clinical Development Agreement for Novel Dry Mouth Treatment 3
(Date:8/6/2015)... , Aug. 6, 2015 Synaptics Inc. ... human interface solutions, today announced collaboration with Microsoft ... Windows 10. Microsoft leveraged Synaptics, deep expertise in ... system. Through stringent testing, Synaptics, ... certified with Microsoft,s Precision TouchPad (PTP) specification empowering ...
(Date:8/4/2015)... 04, 2015 ... announced the addition of the "Digital ... Service), Sub-Segment (Computer Forensics, Network Forensics, Mobile ... Service, Vertical and Region - Global Forecast ... By Component (Hardware, Software, and ...
(Date:7/31/2015)... 2015 BGI llevará a cabo la 10ª Conferencia ... 25 de octubre de 2015, en Shenzhen, ... décimo aniversario este año. Desde su inauguración en 2006, ... anuales más influyentes del mundo en los campos de ... más dinámicas, entusiastas y amenas. ICG-10 se ...
Breaking Biology News(10 mins):Synaptics Chosen for Human Interface Co-Development on Windows 10 2Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 2La 10ª Conferencia Internacional sobre Genómica (ICG-10) comienza en octubre 3
... ports, a public enemy has infiltrated the nation's borders. Taken ... University expert, the adult female alien is the only one ... , The discovery of a single specimen of Sirex noctilio ... nation because the invasive insect species has devastated up to ...
... strains of leprosy-causing bacteria has revealed some surprises about ... across the continents by human migrations. The research, led ... in the 13 May issue of the journal Science, ... findings indicate that the world's existing leprosy infections are ...
... happen - you being in a car wreck or being bitten ... killers win a free trip to the beach. It's really no ... in a wreck are far greater than being a shark's lunch, ... has studied sharks for years. , Worldwide, about one million people ...
Cached Biology News:Alien woodwasp, threat to US pine trees, found in N.Y. 2Leprosy genome tells story of human migrations, French researchers report in Science 2Leprosy genome tells story of human migrations, French researchers report in Science 3Shark attack worries? Driving to the beach is more deadly 2